Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study

D. Paladini, F. Raspagliesi, R. Fontanelli, V. Ntousias

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

In locally advanced cervical cancer, neoadjuvant chemotherapy has been shown to be effective for treatment of both the primary lesion and of metastatic lymph nodes. However, tumor necrosis and regression are often associated with dense fibrosis, which may complicate the surgical management. Forty-five patients with stage IB bulky-IIIB squamous cell carcinoma of the cervix underwent radical hysterectomy plus para-aortic and pelvic lymphadenectomy after one to three courses of different neoadjuvant cisplatin-based chemotherapeutic regimens. Mean operating time was 240 min. One major hemorrage was the only complication related to the para-aortic and pelvic node dissection. The parametrial dissection could be carried out in all patients. Intraoperative complications related to this part of the operation included two rectal and three urinary injuries repaired with no postoperative sequelae. In the specimens, residual parametrial infiltration was present in three out of 15 stage IIB-IIIB cases. The intraoperative complication rate was 13.3% and the gross postoperative complication rate was 4.4%. Postoperatively, only one case of ureteral fistula was recorded, yielding a rate of 2% (1/45). These data are not significantly different from those reported in the literature for radical surgery without neoadjuvant chemotherapy. In locally advanced cervical cancer, radical surgery after neoadjuvant chemotherapy is feasible without any undue increase in morbidity and mortality.

Original languageEnglish
Pages (from-to)296-300
Number of pages5
JournalInternational Journal of Gynecological Cancer
Volume5
Issue number4
Publication statusPublished - 1995

Fingerprint

Induction Chemotherapy
Feasibility Studies
Uterine Cervical Neoplasms
Intraoperative Complications
Drug Therapy
Dissection
Lymph Node Excision
Hysterectomy
Cervix Uteri
Cisplatin
Fistula
Squamous Cell Carcinoma
Fibrosis
Necrosis
Lymph Nodes
Morbidity
Mortality
Wounds and Injuries
Neoplasms
Therapeutics

Keywords

  • Cervical cancer
  • Induction chemotherapy
  • Radical surgery

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Oncology
  • Cancer Research

Cite this

Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study. / Paladini, D.; Raspagliesi, F.; Fontanelli, R.; Ntousias, V.

In: International Journal of Gynecological Cancer, Vol. 5, No. 4, 1995, p. 296-300.

Research output: Contribution to journalArticle

@article{4a4ac7b31fae4dbd85fb23e355822b25,
title = "Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study",
abstract = "In locally advanced cervical cancer, neoadjuvant chemotherapy has been shown to be effective for treatment of both the primary lesion and of metastatic lymph nodes. However, tumor necrosis and regression are often associated with dense fibrosis, which may complicate the surgical management. Forty-five patients with stage IB bulky-IIIB squamous cell carcinoma of the cervix underwent radical hysterectomy plus para-aortic and pelvic lymphadenectomy after one to three courses of different neoadjuvant cisplatin-based chemotherapeutic regimens. Mean operating time was 240 min. One major hemorrage was the only complication related to the para-aortic and pelvic node dissection. The parametrial dissection could be carried out in all patients. Intraoperative complications related to this part of the operation included two rectal and three urinary injuries repaired with no postoperative sequelae. In the specimens, residual parametrial infiltration was present in three out of 15 stage IIB-IIIB cases. The intraoperative complication rate was 13.3{\%} and the gross postoperative complication rate was 4.4{\%}. Postoperatively, only one case of ureteral fistula was recorded, yielding a rate of 2{\%} (1/45). These data are not significantly different from those reported in the literature for radical surgery without neoadjuvant chemotherapy. In locally advanced cervical cancer, radical surgery after neoadjuvant chemotherapy is feasible without any undue increase in morbidity and mortality.",
keywords = "Cervical cancer, Induction chemotherapy, Radical surgery",
author = "D. Paladini and F. Raspagliesi and R. Fontanelli and V. Ntousias",
year = "1995",
language = "English",
volume = "5",
pages = "296--300",
journal = "International Journal of Gynecological Cancer",
issn = "1048-891X",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

TY - JOUR

T1 - Radical surgery after induction chemotherapy in locally advanced cervical cancer. A feasibility study

AU - Paladini, D.

AU - Raspagliesi, F.

AU - Fontanelli, R.

AU - Ntousias, V.

PY - 1995

Y1 - 1995

N2 - In locally advanced cervical cancer, neoadjuvant chemotherapy has been shown to be effective for treatment of both the primary lesion and of metastatic lymph nodes. However, tumor necrosis and regression are often associated with dense fibrosis, which may complicate the surgical management. Forty-five patients with stage IB bulky-IIIB squamous cell carcinoma of the cervix underwent radical hysterectomy plus para-aortic and pelvic lymphadenectomy after one to three courses of different neoadjuvant cisplatin-based chemotherapeutic regimens. Mean operating time was 240 min. One major hemorrage was the only complication related to the para-aortic and pelvic node dissection. The parametrial dissection could be carried out in all patients. Intraoperative complications related to this part of the operation included two rectal and three urinary injuries repaired with no postoperative sequelae. In the specimens, residual parametrial infiltration was present in three out of 15 stage IIB-IIIB cases. The intraoperative complication rate was 13.3% and the gross postoperative complication rate was 4.4%. Postoperatively, only one case of ureteral fistula was recorded, yielding a rate of 2% (1/45). These data are not significantly different from those reported in the literature for radical surgery without neoadjuvant chemotherapy. In locally advanced cervical cancer, radical surgery after neoadjuvant chemotherapy is feasible without any undue increase in morbidity and mortality.

AB - In locally advanced cervical cancer, neoadjuvant chemotherapy has been shown to be effective for treatment of both the primary lesion and of metastatic lymph nodes. However, tumor necrosis and regression are often associated with dense fibrosis, which may complicate the surgical management. Forty-five patients with stage IB bulky-IIIB squamous cell carcinoma of the cervix underwent radical hysterectomy plus para-aortic and pelvic lymphadenectomy after one to three courses of different neoadjuvant cisplatin-based chemotherapeutic regimens. Mean operating time was 240 min. One major hemorrage was the only complication related to the para-aortic and pelvic node dissection. The parametrial dissection could be carried out in all patients. Intraoperative complications related to this part of the operation included two rectal and three urinary injuries repaired with no postoperative sequelae. In the specimens, residual parametrial infiltration was present in three out of 15 stage IIB-IIIB cases. The intraoperative complication rate was 13.3% and the gross postoperative complication rate was 4.4%. Postoperatively, only one case of ureteral fistula was recorded, yielding a rate of 2% (1/45). These data are not significantly different from those reported in the literature for radical surgery without neoadjuvant chemotherapy. In locally advanced cervical cancer, radical surgery after neoadjuvant chemotherapy is feasible without any undue increase in morbidity and mortality.

KW - Cervical cancer

KW - Induction chemotherapy

KW - Radical surgery

UR - http://www.scopus.com/inward/record.url?scp=0029010137&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029010137&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0029010137

VL - 5

SP - 296

EP - 300

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

SN - 1048-891X

IS - 4

ER -